A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
about
A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Multicenter, Randomized, Ope ...... n Korea (0653A-129)(COMPLETED)
@en
type
label
A Multicenter, Randomized, Ope ...... n Korea (0653A-129)(COMPLETED)
@en
prefLabel
A Multicenter, Randomized, Ope ...... n Korea (0653A-129)(COMPLETED)
@en
P4844
P1476
A Multicenter, Randomized, Ope ...... th Metabolic Syndrome in Korea
@en
P3098
NCT00496730
P580
2007-07-01T00:00:00Z
P582
2008-08-01T00:00:00Z